These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

279 related articles for article (PubMed ID: 26535994)

  • 1. Whole Versus Partial Bladder Radiation: Use of an Image-guided Hypofractionated IMRT Bladder-preservation Protocol.
    Kang JJ; Steinberg ML; Kupelian P; Alexander S; King CR
    Am J Clin Oncol; 2018 Feb; 41(2):107-114. PubMed ID: 26535994
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical Outcomes With Dose-Escalated Adaptive Radiation Therapy for Urinary Bladder Cancer: A Prospective Study.
    Murthy V; Masodkar R; Kalyani N; Mahantshetty U; Bakshi G; Prakash G; Joshi A; Prabhash K; Ghonge S; Shrivastava S
    Int J Radiat Oncol Biol Phys; 2016 Jan; 94(1):60-66. PubMed ID: 26547385
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Promising results with image guided intensity modulated radiotherapy for muscle invasive bladder cancer.
    Whalley D; Caine H; McCloud P; Guo L; Kneebone A; Eade T
    Radiat Oncol; 2015 Sep; 10():205. PubMed ID: 26407726
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prospective Study Delivering Simultaneous Integrated High-dose Tumor Boost (≤70 Gy) With Image Guided Adaptive Radiation Therapy for Radical Treatment of Localized Muscle-Invasive Bladder Cancer.
    Hafeez S; Warren-Oseni K; McNair HA; Hansen VN; Jones K; Tan M; Khan A; Harris V; McDonald F; Lalondrelle S; Mohammed K; Thomas K; Thompson A; Kumar P; Dearnaley D; Horwich A; Huddart R
    Int J Radiat Oncol Biol Phys; 2016 Apr; 94(5):1022-30. PubMed ID: 27026308
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical Outcomes of Image Guided Adaptive Hypofractionated Weekly Radiation Therapy for Bladder Cancer in Patients Unsuitable for Radical Treatment.
    Hafeez S; McDonald F; Lalondrelle S; McNair H; Warren-Oseni K; Jones K; Harris V; Taylor H; Khoo V; Thomas K; Hansen V; Dearnaley D; Horwich A; Huddart R
    Int J Radiat Oncol Biol Phys; 2017 May; 98(1):115-122. PubMed ID: 28586948
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Accelerated Hypofractionated Radiation Therapy for Elderly Frail Bladder Cancer Patients Unfit for Surgery or Chemotherapy.
    Hammer L; Laufer M; Dotan Z; Leibowitz-Amit R; Berger R; Felder S; Weiss I; Lawrence YR; Symon Z
    Am J Clin Oncol; 2019 Feb; 42(2):179-183. PubMed ID: 30451730
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hypofractionated intensity modulated radiation therapy in combined modality treatment for bladder preservation in elderly patients with invasive bladder cancer.
    Turgeon GA; Souhami L; Cury FL; Faria SL; Duclos M; Sturgeon J; Kassouf W
    Int J Radiat Oncol Biol Phys; 2014 Feb; 88(2):326-31. PubMed ID: 24411604
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hypofractionated external beam radiotherapy to boost the prostate with ≥85 Gy/equivalent dose for patients with localised disease at high risk of lymph node involvement: feasibility, tolerance and outcome.
    Zilli T; Jorcano S; Escudé L; Linero D; Rouzaud M; Dubouloz A; Miralbell R
    Clin Oncol (R Coll Radiol); 2014 Jun; 26(6):316-22. PubMed ID: 24667210
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prospective phase II study of image-guided local boost using a real-time tumor-tracking radiotherapy (RTRT) system for locally advanced bladder cancer.
    Nishioka K; Shimizu S; Shinohara N; Ito YM; Abe T; Maruyama S; Kinoshita R; Harada K; Nishikawa N; Miyamoto N; Onimaru R; Shirato H
    Jpn J Clin Oncol; 2014 Jan; 44(1):28-35. PubMed ID: 24302759
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The normal tissue sparing obtained with simultaneous treatment of pelvic lymph nodes and bladder using intensity-modulated radiotherapy.
    Søndergaard J; Høyer M; Petersen JB; Wright P; Grau C; Muren LP
    Acta Oncol; 2009; 48(2):238-44. PubMed ID: 18759144
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Trimodality bladder-sparing approach without neoadjuvant chemotherapy for node-negative localized muscle-invasive urinary bladder cancer resulted in comparable cystectomy-free survival.
    Lee CY; Yang KL; Ko HL; Huang RY; Tsai PP; Chen MT; Lin YC; Hwang TI; Juang GD; Chi KH
    Radiat Oncol; 2014 Sep; 9():213. PubMed ID: 25248470
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long-term Tumor Control and Late Toxicity in Patients with Prostate Cancer Receiving Hypofractionated (2.2 Gy) Soft-tissue-matched Image-guided Intensity-modulated Radiotherapy.
    Shimizu D; Yamazaki H; Nishimura T; Aibe N; Okabe H
    Anticancer Res; 2017 Oct; 37(10):5829-5835. PubMed ID: 28982908
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Online adaptive radiotherapy for muscle-invasive bladder cancer: results of a pilot study.
    Foroudi F; Wong J; Kron T; Rolfo A; Haworth A; Roxby P; Thomas J; Herschtal A; Pham D; Williams S; Tai KH; Duchesne G
    Int J Radiat Oncol Biol Phys; 2011 Nov; 81(3):765-71. PubMed ID: 20932678
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impact of image guidance on toxicity and tumour outcome in moderately hypofractionated external-beam radiotherapy for prostate cancer.
    Jereczek-Fossa BA; Maucieri A; Marvaso G; Gandini S; Fodor C; Zerini D; Riva G; Alessandro O; Surgo A; Volpe S; Fanetti G; Arculeo S; Zerella MA; Parisi S; Maisonneuve P; Vavassori A; Cattani F; Cambria R; Garibaldi C; Starzyńska A; Musi G; De Cobelli O; Ferro M; Nolè F; Ciardo D; Orecchia R
    Med Oncol; 2018 Nov; 36(1):9. PubMed ID: 30483899
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Concurrent platinum and docetaxel chemotherapy and external radical radiotherapy in patients with invasive transitional cell bladder carcinoma. A preliminary report of tolerance and local control.
    Varveris H; Delakas D; Anezinis P; Haldeopoulos D; Mazonakis M; Damilakis J; Metaxaris G; Chondros N; Mavromanolakis E; Daskalopoulos G; Dimitrakopoulos A; Kranidis A
    Anticancer Res; 1997; 17(6D):4771-80. PubMed ID: 9494605
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Radical hypofractionated accelerated radiotherapy with cytoprotection for invasive bladder cancer.
    Koukourakis MI; Tsolos C; Touloupidis S
    Urology; 2007 Feb; 69(2):245-50. PubMed ID: 17320657
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of efficacy and toxicity in two different hypofractionated 3D-conformal external beam radiotherapy schedules in localised muscle invasive bladder cancer.
    Kouloulias V; Mosa E; Tolia M; Kantzou I; Koliarakis N; Platoni K; Georgakopoulos I; Siatelis A; Sarris G; Beli I; Chrisofos M; Kelekis N
    J BUON; 2013; 18(4):942-8. PubMed ID: 24344021
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long-term outcomes in treatment of invasive bladder cancer with concomitant boost and accelerated hyperfractionated radiation therapy.
    Canyilmaz E; Yavuz MN; Serdar L; Uslu GH; Zengin AY; Aynaci O; Haciislamoglu E; Bahat Z; Yoney A
    Int J Radiat Oncol Biol Phys; 2014 Nov; 90(3):562-9. PubMed ID: 25160608
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Radical radiotherapy for bladder cancer: retrospective analysis of a series of 459 patients treated in an Italian institution.
    Tonoli S; Bertoni F; De Stefani A; Vitali E; De Tomasi D; Caraffini B; Scheda A; Bertocchi M; Somensari A; Buglione M; Magrini SM
    Clin Oncol (R Coll Radiol); 2006 Feb; 18(1):52-9. PubMed ID: 16477920
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Is Ultra Hypofractionated Radiation Therapy a Safe and Effective Treatment for Invasive Bladder Cancer in the Elderly?: A Retrospective Single Institution Review.
    Symon N; Mattout J; Lewin R; Hammer L; Laufer M; Berger R; Leibowitz R; Dotan Z; Ben-Ayun M; Tsvang L; Weiss I; Symon Z
    Am J Clin Oncol; 2021 Jul; 44(7):369-373. PubMed ID: 33927135
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.